Raul Shah braves the snow and cold to join Morning Movers from the NYSE floor. He discusses Hims & Hers (HIMS) ahead of earnings. The company's faced multiple headwinds including legal issues from Novo Nordisk (NVO) and its sale of a semaglutide weight-loss product. Raul says the earnings call "will be crucial" for investors to get some clarity from the company's leaders and more insights on Hims & Hers next steps. Raul points to other markets like hormonal treatment as a potential growth area for HIMS.

======== Schwab Network ========

Empowering every investor and trader, every market day.

Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe

Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185

Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7

Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch

Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore

Watch on DistroTV - https://www.distro.tv/live/schwab-network/

Follow us on X – / schwabnetwork

Follow us on Facebook – / schwabnetwork

Follow us on LinkedIn - / schwab-network

About Schwab Network - https://schwabnetwork.com/about